Neuro-oncology
The clinical research activity is centered on glioblastoma, with interest in treatment strategies for newly diagnosed glioblastoma multiforme and related central nervous system malignancies.
- Glioblastoma
- Glioblastoma multiforme
- Central nervous system tumours
Research in this area reflects a focus on difficult-to-treat brain tumours managed within oncology and neuro-oncology care pathways.
Radiation oncology
Clinical interest includes the use of radiotherapy as part of combined treatment approaches for brain tumour management, with attention to integration alongside other anticancer therapies.
- Radiotherapy
- Combined modality cancer treatment
- Brain tumour irradiation
This area connects tumour control in glioblastoma with treatment planning in radiation oncology.
Pharmacological cancer therapy
The sponsor’s research landscape includes systemic treatment for glioblastoma, with interest in temozolomide and other anticancer agents used in combination settings.
- Temozolomide
- Anticancer pharmacotherapy
- Combination treatment
Work in this domain is aligned with chemotherapy-based management of aggressive brain tumours.
Supportive antifungal therapy in oncology
Clinical interest also extends to itraconazole as an adjunct within oncologic treatment, reflecting exploration of non-standard therapeutic options in cancer care.
- Itraconazole
- Adjunctive oncology therapy
- Repurposed medicines
This area links drug repurposing with management of glioblastoma in a clinical research setting.
